DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

ImmunoGen (NASDAQ: IMGN)

7.63 1.43 (23.06%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IMGN $7.63 23.06%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.75
Previous Close $6.20
Daily Range $6.68 - $8.45
52-Week Range $5.34 - $17.80
Market Cap $655.7M
P/E Ratio -6.46
Dividend (Yield) $0.00 (0.0%)
Volume 11,635,874
Average Daily Volume 2,184,230
Current FY EPS -$0.72

Sector

Healthcare

Industry

Drugs

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website: http://www.immunogen.com/

News & Commentary Rss Feed

ImmunoGen, Inc. Gets Into the Black, Accounting Wise

But it's still burning cash.

Gulf Resources (GURE) Soars on Natural Gas Discovery, ImmunoGen (IMGN) and Synaptics (SYNA) ...

Update: ImmunoGen Earnings

ImmunoGen Shares Surge 30% Following Earnings

ImmunoGen's (IMGN) CEO Daniel Junius on Q2 2015 Results - Earnings Call Transcript

ImmunoGen (IMGN) Q4 2014 Results - Earnings Call Webcast

Earnings Scheduled For January 30, 2015

Earnings Peek: ImmunoGen Is Undervalued

Why ImmunoGen, Inc. Stock Was Decimated in December

ImmunoGen was the worst biotech stock in December after it and its partner Roche released disappointed study data. Find out whether the mauling was merited or if ImmunoGen shares could be a bargain here.

ImmunoGen: MARIANNE Failed? A Hair Raising Perspective

See More IMGN News...

IMGN's Top Competitors

IMGN $7.63 (23.06%)
Current stock: IMGN
AMGN $152.26 (-2.63%)
Current stock: AMGN
GILD $104.83 (0.62%)
Current stock: GILD
BIIB $389.16 (10.17%)
Current stock: BIIB